PMID- 36536281 OWN - NLM STAT- MEDLINE DCOM- 20221221 LR - 20221230 IS - 1528-3658 (Electronic) IS - 1076-1551 (Print) IS - 1076-1551 (Linking) VI - 28 IP - 1 DP - 2022 Dec 19 TI - Single-cell transcriptomic analysis reveals differential cell subpopulations and distinct phenotype transition in normal and dissected ascending aorta. PG - 158 LID - 10.1186/s10020-022-00584-4 [doi] LID - 158 AB - BACKGROUND: Acute thoracic aortic dissection (ATAD) is a fatal condition characterized by tear of intima, formation of false lumen and rupture of aorta. However, the subpopulations of normal and dissected aorta remain less studied. METHODS: Single-cell RNA sequencing was performed including 5 patients with ATAD and 4 healthy controls. Immunohistochemistry and immunofluorescence were used to verify the findings. RESULTS: We got 8 cell types from human ascending aorta and identified 50 subpopulations including vascular smooth muscle cells (VSMCs), endothelial cells, fibroblasts, neutrophils, monocytes and macrophages. Six transmembrane epithelial antigen of prostate 4 metalloreductase (STEAP4) was identified as a new marker of synthetic VSMCs. CytoTRACE identified subpopulations with higher differentiation potential in specified cell types including synthetic VSMCs, enolase 1(+) fibroblasts and myeloid-derived neutrophils. Synthetic VSMCs-derived C-X-C motif chemokine ligand 12 (CXCL12) might interact with neutrophils and fibroblasts via C-X-C motif chemokine receptor 4 (CXCR4) and atypical chemokine receptor 3 (ACKR3), respectively, which might recruit neutrophils and induce transdifferentitation of fibroblasts into synthetic VSMCs. CONCLUSION: We characterized signatures of different cell types in normal and dissected human ascending aorta and identified a new marker for isolation of synthetic VSMCs. Moreover, we proposed a potential mechanism that synthetic VSMCs might interact with neutrophils and fibroblasts via CXCL12-CXCR4/ACKR3 axis whereby deteriorating the progression of ATAD, which might provide new insights to better understand the development and progression of ATAD. CI - (c) 2022. The Author(s). FAU - He, Yu-Bin AU - He YB AD - Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, No.241, West Huaihai Road, Shanghai, 200030, China. FAU - Jin, Hai-Zhen AU - Jin HZ AD - Department of Central Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. FAU - Zhao, Jin-Long AU - Zhao JL AD - Department of Cardiovascular Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. FAU - Wang, Chong AU - Wang C AD - Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, No.241, West Huaihai Road, Shanghai, 200030, China. FAU - Ma, Wen-Rui AU - Ma WR AD - Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. FAU - Xing, Jie AU - Xing J AD - Department of Biobank, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. FAU - Zhang, Xiao-Bin AU - Zhang XB AD - Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, No.241, West Huaihai Road, Shanghai, 200030, China. FAU - Zhang, Yang-Yang AU - Zhang YY AD - Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, No.241, West Huaihai Road, Shanghai, 200030, China. FAU - Dai, Huang-Dong AU - Dai HD AD - Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, No.241, West Huaihai Road, Shanghai, 200030, China. FAU - Zhao, Nai-Shi AU - Zhao NS AD - Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, No.241, West Huaihai Road, Shanghai, 200030, China. FAU - Zhang, Jian-Feng AU - Zhang JF AD - Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, No.241, West Huaihai Road, Shanghai, 200030, China. jeff_cardiosur@163.com. FAU - Zhang, Guan-Xin AU - Zhang GX AD - Department of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, No.168, Changhai Road, Shanghai, China. gxzhang_ctsur@163.com. FAU - Zhang, Jing AU - Zhang J AUID- ORCID: 0000-0003-2265-565X AD - Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, No.241, West Huaihai Road, Shanghai, 200030, China. zhangjing_cvs@126.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20221219 PL - England TA - Mol Med JT - Molecular medicine (Cambridge, Mass.) JID - 9501023 SB - IM MH - Male MH - Humans MH - *Aorta, Thoracic MH - Endothelial Cells MH - Transcriptome MH - Aorta MH - Phenotype MH - *Aortic Dissection PMC - PMC9764678 OTO - NOTNLM OT - Acute thoracic aortic dissection OT - CXCL12 OT - Cell differentiation trajectory OT - Cell-cell interaction OT - Phenotypic switch OT - Single-cell RNA sequencing COIS- The authors declare that they have no conflict of interest. EDAT- 2022/12/20 06:00 MHDA- 2022/12/22 06:00 PMCR- 2022/12/19 CRDT- 2022/12/19 23:43 PHST- 2022/05/17 00:00 [received] PHST- 2022/12/01 00:00 [accepted] PHST- 2022/12/19 23:43 [entrez] PHST- 2022/12/20 06:00 [pubmed] PHST- 2022/12/22 06:00 [medline] PHST- 2022/12/19 00:00 [pmc-release] AID - 10.1186/s10020-022-00584-4 [pii] AID - 584 [pii] AID - 10.1186/s10020-022-00584-4 [doi] PST - epublish SO - Mol Med. 2022 Dec 19;28(1):158. doi: 10.1186/s10020-022-00584-4.